InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,828.94
(
0.05%
)
Post# of 3108
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whirlybird

Send PM Follow Ignore
Followers 2
Posts 133
Boards Moderated 0
Alias Born 11/12/2010

whirlybird

Re: None

Wednesday, 04/02/2014 4:46:40 PM

Wednesday, April 02, 2014 4:46:40 PM

Post# of 3108
Baxter will be the first out the door

with completion of a P3 study for cardiac disease this year using PCT cells. NBS will be a beneficiary of positive news.
Even if treating Dilated Cardiomegaly is not exactly the same as treating Acute MI (AMI)as Mesoblast or NBS hope to do or Chronic Myocardial Ischemia as BAX hopes to do, many aspects of current treatments are the same, and there will be cross-over usage eventually following approval of PCT stem cells for one or another form of cardiac disease.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent LSTA News
More LSTA News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!